TRIANA Biomedicines
Artyom Alekseyenko is a seasoned scientist with extensive experience in the field of molecular genetics and cellular biology. Currently serving as Principal Scientist at TRIANA Biomedicines since February 2022 and Senior Scientist I at Constellation Pharmaceuticals since April 2019, Artyom has a strong background in academic and research institutions. Previous roles include Instructor in the Department of Medicine at Brigham and Women's Hospital, and postdoctoral fellow at both Harvard Medical School and Howard Hughes Medical Institute. Artyom's educational qualifications include post-doctoral training in Molecular Genetics from Harvard Medical School, a Ph.D. in Cell/Cellular and Molecular Biology from the Institute of Cytology and Genetics SB RAS, and a BS/MS in Biology/Cytology and Genetics from Novosibirsk State University.
This person is not in any offices
TRIANA Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated thebest-in-class platform and initiated multiple programs across different disease areas.